Skip to Content

Melphalan Injection

Last Updated: May 28, 2020
Status: Current

Products Affected - Description
    • Melphalan powder for solution for injection, Mylan Institutional, 50 mg, vial, 1 count, NDC 67457-0195-01
    • Melphalan powder for solution for injection, Par Pharmaceuticals, 50 mg, vial, 1 count, NDC 42023-0129-01 - discontinued
    • Melphalan powder for solution for injection, Teva, 50 mg, vial, 1 count, NDC 45963-0686-02
Reason for the Shortage
    • Athenex did not provide a reason for the shortage.
    • Dr. Reddy's has melphalan injection available.
    • Fresenius Kabi has melphalan injection available.
    • Meitheal has melphalan injection available.
    • Mylan Institutional did not provide a reason for the shortage.
    • Par discontinued melphalan injection in January 2020.
    • Sagent is not currently marketing melphalan injection.
    • Spectrum has Evomela injection available.
Available Products
    • Evomela powder for solution for injection, Spectrum, 50 mg, vial, 1 count, NDC 68152-0109-00
    • Melphalan powder for solution for injection, Athenex, 50 mg, vial, 1 count, NDC 70860-0214-61
    • Melphalan powder for solution for injection, Dr. Reddy's, 50 mg, vial, 1 count, NDC 43598-0392-48
    • Melphalan powder for solution for injection, Fresenius Kabi, 50 mg, vial, 1 count, NDC 63323-0760-20
    • Melphalan powder for solution for injection, Meitheal Pharmaceuticals, 50 mg, vial, 1 count, NDC 71288-0112-90

Estimated Resupply Dates

    • Mylan has melphalan 50 mg vials on back order and the company estimates a release date of late-July 2020.
    • Teva has melphalan 50 mg vials on back order and the company estimates a release date of July 2020.

Updated

Updated May 28, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 28, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide